Tempest Therapeutics Total Debt vs. Book Value Per Share
| TPST Stock | USD 6.99 0.08 1.13% |
For Tempest Therapeutics profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Tempest Therapeutics to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Tempest Therapeutics utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Tempest Therapeutics's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Tempest Therapeutics over time as well as its relative position and ranking within its peers.
Check out World Market Map. Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tempest Therapeutics. If investors know Tempest will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tempest Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Tempest Therapeutics is measured differently than its book value, which is the value of Tempest that is recorded on the company's balance sheet. Investors also form their own opinion of Tempest Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Tempest Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tempest Therapeutics' market value can be influenced by many factors that don't directly affect Tempest Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tempest Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Tempest Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tempest Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Tempest Therapeutics Book Value Per Share vs. Total Debt Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Tempest Therapeutics's current stock value. Our valuation model uses many indicators to compare Tempest Therapeutics value to that of its competitors to determine the firm's financial worth. Tempest Therapeutics is rated fourth in total debt category among its peers. It is rated below average in book value per share category among its peers . The ratio of Total Debt to Book Value Per Share for Tempest Therapeutics is about 4,857,730 . At this time, Tempest Therapeutics' Book Value Per Share is comparatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Tempest Therapeutics by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Tempest Total Debt vs. Competition
Tempest Therapeutics is rated fourth in total debt category among its peers. Total debt of Health Care industry is at this time estimated at about 2.66 Billion. Tempest Therapeutics maintains roughly 15.37 Million in total debt contributing less than 1% to equities under Health Care industry.
Tempest Book Value Per Share vs. Total Debt
Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Tempest Therapeutics |
| = | 15.37 M |
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.
Tempest Therapeutics |
| = | 3.16 X |
The naive approach to look at Book Value per Share is to compare it to current stock price. If Book Value per Share is higher than the currently traded stock price, the company can be considered undervalued. However, investors must be aware that conventional calculation of Book Value does not include intangible assets such as goodwill, intellectual property, trademarks or brands and may not be an appropriate measure for many firms.
Tempest Book Value Per Share Comparison
Tempest Therapeutics is currently under evaluation in book value per share category among its peers.
Tempest Therapeutics Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Tempest Therapeutics, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Tempest Therapeutics will eventually generate negative long term returns. The profitability progress is the general direction of Tempest Therapeutics' change in net profit over the period of time. It can combine multiple indicators of Tempest Therapeutics, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Operating Income | -42 M | -44.1 M | |
| Income Before Tax | -41.8 M | -43.9 M | |
| Net Loss | -41.8 M | -43.9 M | |
| Total Other Income Expense Net | 183 K | 192.2 K | |
| Income Tax Expense | -37.7 M | -35.8 M | |
| Net Loss | -25.5 M | -26.7 M | |
| Net Interest Income | 183 K | 192.2 K | |
| Interest Income | 1.5 M | 1.6 M | |
| Net Loss | -41.8 M | -43.9 M | |
| Change To Netincome | 3 M | 3.1 M | |
| Net Loss | (1.50) | (1.57) | |
| Income Quality | 0.79 | 0.62 | |
| Net Income Per E B T | 1.14 | 1.11 |
Tempest Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Tempest Therapeutics. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Tempest Therapeutics position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Tempest Therapeutics' important profitability drivers and their relationship over time.
Learn to be your own money manager
Our tools can tell you how much better you can do entering a position in Tempest Therapeutics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Economic Indicators Now
Economic IndicatorsTop statistical indicators that provide insights into how an economy is performing |
| All Next | Launch Module |
Use Investing Themes to Complement your Tempest Therapeutics position
In addition to having Tempest Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Baby Boomer Prospects Thematic Idea Now
Baby Boomer Prospects
Equities with large market capitalization that account for significant contribution to overall economic growth especially within dividend-paying instruments and stocks from healthcare and financial sectors. The Baby Boomer Prospects theme has 73 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Baby Boomer Prospects Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Tempest Stock Analysis
When running Tempest Therapeutics' price analysis, check to measure Tempest Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tempest Therapeutics is operating at the current time. Most of Tempest Therapeutics' value examination focuses on studying past and present price action to predict the probability of Tempest Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tempest Therapeutics' price. Additionally, you may evaluate how the addition of Tempest Therapeutics to your portfolios can decrease your overall portfolio volatility.